Volume 10; Issue supp-S2

Main
Fibrinolysis and Proteolysis
Volume 10; Issue supp-S2

Fibrinolysis and Proteolysis

Volume 10; Issue supp-S2

1

Genetic studies of complex diseases: giant steps from promise to proof

P.E. Slagboom, C. Kluft

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 203 KB

english, 1996

2

Functional variants in candidate genes involved in vascular matrix remodelling

A.M. Henney, S. Ye

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 255 KB

english, 1996

3

Genetic and environmental determinants of factor VII, fibrinogen and PAI-1

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 197 KB

english, 1996

4

Fibrinolytic capacity and risk of myocardial infarction

J.G. van der Bom, M.L. Bots, F. Haverkate, D.E. Grobbee, C. Kluft

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 412 KB

english, 1996

5

Alu-repeat polymorphism in the tissue-type plasminogen activator (t-PA) gene, t-PA levels and risk of familial myocardial infarction (MI)

L. Iacoviello, A. Di Castelnuovo, P. de Knijff, A. D'Orazio, C. Amore, C. Kluft, M.B. Donati

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 321 KB

english, 1996

6

Plasma factor VII levels are determined by polymorphisms in the factor VII gene

J. Bentzen, E.M. Bladbjerg, M.P.M. de Maat, P. Marckmann

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 175 KB

english, 1996

7

Study design for the identification of loci affecting human longevity

B.T. Heijmans, C. Kluft, M.L. Bots, A.M. Lagaay, A. Brand, D.E. Grobbee, D.L. Knook, P.E. Slagboom

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 195 KB

english, 1996

8

Resistance to activated protein C evaluated with APTT-based methods and DNA analysis

A. Pannocchia, A. Giorgianni, P. Schinco, M. Bazzan, C. Foli, A. Vaccarino, B. Montaruli

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 189 KB

english, 1996

9

Coagulation and fibrinolysis in children with APC-resistance: a population study

U. Nowak-Göttl, H. Vielhaber, R. Schneppenheim, H.G. Koch

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 242 KB

english, 1996

10

Isolation and storage of DNA for population studies

S. Droog, N. Lakenberg, I. Meulenbelt, M.P.M. de Maat, L.G.M. Huisman, A.F.H. Jie, P.E. Slagboom

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 182 KB

english, 1996

11

NASBA® factor V Leiden QL; a new genotype assay to detect the factor V Leiden mutation in anticoagulated whole blood

F. Roeles, W. Kok, B. Top, H. Adriaanse, N. Tacken, B. van Gemen

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 107 KB

english, 1996

12

The role of plasminogen activators in the development of atherosclerotic and restenotic lesions

F. Lupu, D. Gerard, A. Esmail, A. Moradoghli-Haftvani, V.V. Kakkar

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 303 KB

english, 1996

13

The effect of percutaneous transluminal coronary angioplasty on haemostasis

K. Várnai, F. Gürtler, L. Szatmáry, M.E. Scholz

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 236 KB

english, 1996

14

Thrombin receptor and urokinase-type plasminogen activator are colocalized in vascular smooth muscle cells derived from human carotid atherosclerotic plaques

R. Dechend, X. Mo, W. Schulz, M. Gross, M. Praus, R. Dietz, D.C. Gulba

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 352 KB

english, 1996

15

Enhanced soluble thrombomodulin, t-PA and u-PA concentrations caused by short-term endothelial damage during percutaneous cardiac catheterisation

H. Vielhaber, H.G. Kehl, D. Kececioglu, J. Vogt, U. Nowak-Göttl

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 203 KB

english, 1996

16

Factor XII dependent fibrinolytic activity is decreased in the acute phase of myocardial or cerebral infarction

M. Spannagl, P. Henselmann, M. Weber, J. Gram, J. Jespersen, C. Kluft

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 183 KB

english, 1996

17

Effects of self-administration of high doses androgenic-anabolic steroids on fibrinolytic activity in non elite bodybuilders

C. Pernot, F. Hartgens, H.A. Keizer, H. Kuipers, K. Hamulyák

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

18

Endothelial vWf and t-PA release after incubation with different concentrations of asparaginase and dexamethasone

U. Nowak-Göttl, M. Erben, G. Münstermann, B. Kehrel, J. Boos, J.E.A. Wolff

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

19

t-PA activity and antigen in thrombolytic treatment with rt-PA in children

I.M. Risseeuw-Appel, I. Dekker, R.L. Stigter, C.L. van Kessel-Bakvis

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

20

Activation of coagulation and fibrinolysis in HIV-infected patients

P. Toulon, J.C. Gris, N. Candia, D. Salmon, D. Sereni, D. Sicard, J.F. Schved

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 256 KB

english, 1996

21

PAI-1 reduction after treatment with glutathione in NIDDM

V. Martina, G.A. Bruno, A. Pannocchia, E. Zumpano, M. Tagliabue, F. Trucco, A. Giorgianni, S. Stella, G.P. Pescarmona

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 223 KB

english, 1996

22

A monoclonal antibody against the COOH-terminal site of α2-antiplasmin reveals heterogeneity in the non-plasminogen binding form of α2-antiplasmin

F.W.G. Leebeek, P. Los, C. Kluft

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 894 KB

english, 1996

23

Effects of infection with recombinant adenovirus on human vascular endothelial and smooth muscle cells

P.H.A. Quax, M.L.M. Lamfers, J.M. Grimbergen, J. Teeling, R.C. Hoeben, G.P. van Nieuw Amerongen, V.W.M. van Hinsbergh

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 665 KB

english, 1996

24

Role of urokinase plasminogen activator in human breast cancer: Active involvement of stromal fibroblasts

C.E.P. van Roozendaal, J.G.M. Klijn, A.M. Sieuwerts, S.C. Henzen-Logmans, J.A. Foekens

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 897 KB

english, 1996

25

The effect of treatment of Helicobacter pylori infection on gastric mucosal plasminogen activators

J.M. Götz, J.W. Ravensbergen, H.W. Verspaget, I. Biemond, C.F.M. Sier, G.J.A. Offerhaus, C.B.H.W. Lamers, R.A. Veenendaal

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 513 KB

english, 1996

26

Localization of the components of the plasminogen activation system in cutaneous melanocytic lesions — a minireview

T.J. de Vries, D.J. Ruiter, U.H. Weidle, G.N.P. van Muijen

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 329 KB

english, 1996

27

The plasminogen activation system in rheumatoid arthritis

H.K. Ronday, F.C. Breedveld, J.H. Verheijen

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 342 KB

english, 1996

28

Intraperitoneal coagulation and fibrinolysis during inflammation: In vivo and in vitro observations

T. Sitter, M. Gödde, M. Spannagl, H. Fricke, T. Kooistra

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 952 KB

english, 1996

29

Decreased serum tetranectin in multiple myeloma — relation to disease stage

M. Steiner, J. Reincke, B. Krammer-Steiner, M. Freund

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 255 KB

english, 1996

30

Inhibition of urokinase-type and tissue-type plasminogen activator — mediated plasminogen activation by doxycycline

R. Hanemaaijer, H. Visser, C.M. van den Hoogen, T. Sorsa, V.W.M. van Hinsbergh

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 223 KB

english, 1996

31

Various approaches to standardization and the importance of measurement accuracy

J. Gram, J. Jespersen, C. Kluft, P. Declerck

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 317 KB

english, 1996

32

DVT exclusion in symptomatic outpatients: use of a rapid D-dimer immunofiltration assay and comparison with three enzyme immuno assays

A. Pannocchia, I. Chiappino, S. Valpreda, M. Bazzan, A. Giorgianni, G. Lanfranco, F. Pautasso, C. Rabbia, D. Roglia, E. Aluffi

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 190 KB

english, 1996

33

Criteria for a specific plasmin inhibition test (SPIT) in human plasma

P. Meijer, C. Kluft

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 254 KB

english, 1996

34

Usefulness and limitations of actilyse® for standardisation of tissue-type plasminogen activator (t-PA) assays in blood

L.G.M. Huisman, J.M.T. van Griensven, C. Kluft

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 237 KB

english, 1996

35

Comparison between functional and immunochemical assays for fibrinogen determination in a family cohort study

G. Siegert, S. Bergmann, J. Graessler, A. Paetzold, H.-E. Schroeder, W. Jaross

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 262 KB

english, 1996

36

The radial immunodiffusion assay for plasma Histidine-rich Glycoprotein (HRG) based on a polyclonal antibody, shows a different specificity towards the two variants of a common amino acid polymorphism

B.C. Hennis, J.J.M.L. Hoffmann, C. Kluft

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

37

Chromolize™ PAI-1: a new assay for active plasminogen activator inhibitor type 1 adapted for use with Stabilyte™ vials

N. Bergsdorf, E. Johansson, B. Norrman

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 246 KB

english, 1996

38

Influence of mental stress on fibrinogen, von Willebrand factor and tissue-type plasminogen activator antigen

H. Snieder, A.C. Huizink, D.I. Boomsma, L.J.P. van Doornen

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 259 KB

english, 1996

39

Relation of tissue-type plasminogen activator and plasminogen activator inhibitor to metabolic variables and atherosclerosis in a family cohort study

G. Siegert, S. Bergmann, J. Graessler, A. Paetzold, H.-E. Schroeder, W. Jaross

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 256 KB

english, 1996

40

Analysis of activation markers of coagulation, fibrinolysis and inflammation in unstable angina by probit transformation

L.M. Biasucci, M.P.M. de Maat, A. Meo, W. van der Greef, F. Summaria, G. Quaranta, G. Liuzzo, C. Kluft, A. Maseri

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 214 KB

english, 1996

41

Quality control in quantitation of components of the plasminogen activator system in tumour extracts

Th.J. Benraad, A. Geurts-Moespot, N. Grebenschikov, J. de Witte, J. Heuvel, C.G.J. Sweep

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 254 KB

english, 1996

42

Influence of blood handling on determination of plasma resistance against activated protein C

O.D. Pedersen, J. Sidelmann, J. Gram, J. Jespersen

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 136 KB

english, 1996

43

The use of Stabilyte® plasma may cause changes in pH in the assay of some fibrinolysis analytes and might effect results

P. Meijer, F. van der Ham, C. Kluft

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 181 KB

english, 1996

44

Circadian patterns of plasma t-PA and PAI-1 antigen levels in patients with severe peripheral atherosclerosis

F. Andreotti, R. Prevost, A. Lupi, J. Hamilton, A.C.W. de Bart, L.G.M. Huisman, A. Maseri, C. Kluft

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

45

Activated protein C response and cardiovascular risk factors in the elderly — The Rotterdam Study

M.L. Bots, J.G. van der Bom, F. Haverkate, P. Meijer, A. Hofman, D.E. Grobbee, C. Kluft

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 355 KB

english, 1996

46

A novel method, COAMATIC® Plasmin Inhibitor, for the specific determination of Plasmin Inhibitor activity in plasma

S. Billing Clason, P. Meijer, C. Kluft, E. Ersdal

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 201 KB

english, 1996

47

External quality assessment of thrombophilia testing in Europe

F. Haverkate, I.D. Walker, J. Conkie

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 67 KB

english, 1996

48

Update 1996: Blood collection and handling procedures for assessment of plasminogen activators and inhibitors (Leiden Fibrinolysis Workshop)

C. Kluft, P. Meijer

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 915 KB

english, 1996

49

Urokinase and tissue-type plasminogen activator stimulate human vascular smooth muscle cell migration

M.J. Wijnberg, N.M.E. Nieuwenbroek, J. Slomp, P.H.A. Quax, J.H. Verheijen

Journal:

Fibrinolysis and Proteolysis

Year:

1996

Language:

english

File:

PDF, 353 KB

english, 1996